2 citations
,
March 2022 in “PubMed” This review concludes that oral nutraceuticals like Nutrafol® and Viviscal® modestly promote hair growth in individuals with androgenetic alopecia and might be considered as supplementary treatments.
April 2017 in “Journal of dermatology & cosmetology” In this controlled study, a 6-month treatment with the nutraceutical product ViviScal® reduced telogen hair fibers and increased total hair fibers in 83% of participants with Telogen Effluvium, who also reported improved hair and nail growth, skin appearance, and overall quality of life.
40 citations
,
May 2018 in “PubMed” In this randomized, double-blind, placebo-controlled study, daily use of the Nutrafol® Women's Capsules nutraceutical significantly increased the number of terminal and vellus hairs and improved hair quality in women with self-perceived thinning over six months, without any reported adverse events.
August 2013 in “Pharmacy Today” In a recent study of 15 women with self-perceived hair loss, Viviscal supplementation was associated with an increase in terminal hairs and subjective improvement in hair characteristics.
January 2018 in “Hair transplant forum international” This article discusses a novel multi-targeting approach to treating hair loss using standardized nutraceuticals but reports no new clinical results.